Philips has received FDA 510(k) clearance for its noninvasive test of liver tissue stiffness. The FDA nod (PDF) positions Philips to pitch its ultrasound ElastQ Imaging offering as an alternative to ...
Although histopathological analysis of liver tissue is still the reference standard for the evaluation of disease progression in patients with chronic liver disease, a distinct change in clinical ...
The FDA has qualified its first artificial intelligence tool to help drug developers evaluate fatty liver disease in their ...
New European and Latin American guidelines on the use of noninvasive tests for liver evaluation are the first to specifically address an approach that has become the standard in much of the developed ...
Chronic liver disease (CLD) is responsible for significant morbidity and mortality. Most liver-related outcomes occur in people with advanced CLD, yet liver disease can be asymptomatic until the late ...
A research team from the Department of Medicine III at MedUni Vienna and University Hospital Vienna has conducted a large-scale study showing the important value of repeated liver assessments by a ...
PARIS & WALTHAM, Mass.--(BUSINESS WIRE)--Echosens, a high-technology company offering the FibroScan ® family of products, is pleased to announce its strong presence at the upcoming American ...
Liver damage often starts slowly, and early signs are easy to miss. The condition can occur when the liver is injured or diseased, leading to symptoms like jaundice, abdominal swelling, and fatigue, ...
Your skin can reveal secrets about your liver's health. Subtle changes like yellowing, persistent itching without a rash, or ...
On Thursday, the Food and Drug Administration announced its approval of the first ever therapeutic treatment targeting metabolic dysfunction-associated steatohepatitis (MASH). This represents a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback